Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$138,204,124
+$8,251,998 QoQ
Shares Held
544,175
+2.4% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#252
of 4,664 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Zurich Insurance Group Ltd/FI holds $782,126,991 across 9 Drug Manufacturers - General names. JNJ ranks #2 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
205,905 | $246,968,654 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
544,175 | $138,204,124 | |
| 3 | AZN |
Astrazeneca PLC
|
621,907 | $117,926,005 | |
| 4 | ABBV |
AbbVie Inc.
|
323,672 | $81,448,822 | |
| 5 | MRK |
Merck & Co., Inc.
|
631,197 | $81,108,814 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
354,330 | $44,766,052 | |
| 7 | AMGN |
Amgen Inc
|
113,643 | $41,152,403 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
398,360 | $22,953,503 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $138,204,124 | 544,175 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $129,952,126 | 531,632 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $176,362,376 | 852,198 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $107,718,451 | 580,943 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $65,284,586 | 427,395 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $130,779,102 | 788,586 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $68,467,880 | 473,433 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $78,873,629 | 486,694 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $21,208,546 | 145,105 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,919,709 | 31,100 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,874,614 | 31,100 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,843,825 | 31,100 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,147,672 | 31,100 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $82,871,835 | 534,657 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $150,373,665 | 851,252 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $154,419,960 | 945,274 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $145,811,329 | 821,426 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $169,117,296 | 954,225 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,320,277 | 31,100 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,939,671 | 55,354 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,311,274 | 20,100 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,303,435 | 20,100 | Shares | Defined | 2021-05-17 | |
| 2020-03-31 | $118,109,577 | 900,706 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||